Blood pressure and disability: Novus orsa

Hypertension

Volumn 50, Issue 6, 2007, Pages 1006-1008

  Elias, Merrill F ^a   Elias, Penelope K ^a  

^a University of Maine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; DISEASE ASSOCIATION; FUNCTIONAL DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; MUSCLE STRENGTH; NEUROIMAGING; NOTE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACTIVITIES OF DAILY LIVING; ANTIHYPERTENSIVE AGENTS; COGNITION; DEMENTIA; DISABILITY EVALUATION; DISABLED PERSONS; HUMANS; HYPERTENSION;

EID: 36448932297     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.100883     Document Type: Note

References (9)

1. Inzitari D, Basile AM, Carlucci G. Vascular cognitive impairment and disability. In: Erkinjuntti T, Gauthier S, eds. Vascular Cognitive Impairment. London, United Kingdom: Martin Dunitz Ltd; 2002:227-236.
2. Hajjar I, Lackland DT, Cupples A, Lipsitz L. Association between concurrent and remote blood pressure and disability in older adults. Hypertension. 2007;50:1026-1032.
3. Pinsky JL, Branch LG, Jette AM, Haynes SG, Feinleib M, Cornoni-Huntley JC, Bailey KR. Framingham disability study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol. 1985;122:644-656.
4. Gil-Nuñez AC, Vivancos-Mora J. Blood pressure as a risk factor for stroke and the impact of antihypertensive treatment. Cerebrovascular Dis. 2005;20(suppl 2):40-52.
5. Hubert HB, Fries JF. Predictors of physical disability after age 50. Six-year longitudinal study in a runners club and a university population. Ann Epidemiol. 1994;4:285-294.
6. Stuck AE, Walthert JM, Nikolaus T, Büla CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med. 1999;48:445-469.
7. Loehlin, JC. Latent Variable Models: An Introduction to Factor, Path and Structural Equation Analysis. Mahwah, NJ: Lawrence Erlbaum Associates; 2004.
8. Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. The SAGE Study Group. Systematic assessment of geriatric drug use via epidemiology. Arch Intern Med. 2000;160:53-60.
9. Onder G, Penninx BW, Balkrishanan R, Fried LP, Chaves PH, Williamson J, Carter C, Di Bari M, Guralnik JM, Pahor M. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359:926 -930.